On Sep 30, Zacks Investment Research upgraded Rambus Inc. ( RMBS ) to a Zacks Rank #1 (Strong Buy).The upgrade came on the back of positive estimate revisions over the last 60 days. Also, Rambus’s shares are up 29.7% year to date and posted a strong return of 15.6% over the past six months. […]
On Sep 30, Zacks Investment Research downgraded KBR, Inc . ( KBR ) by a notch to a Zacks Rank #5 (Strong Sell) largely due to persistent weakness. […]
Fellowes Brands Acquires Action-Sports Photography Innovator Optrix, Inc. Partnership Seeks to Create a New Standard in Mobile Innovation PR Newswire ITASCA, Ill., Sept. 30, 2014 ITASCA, Ill […]
Hesco Armor – Protecting the Protectors PR Newswire CHARLESTON, South Carolina, September 30, 2014 CHARLESTON, South Carolina , September 30, 2014 /PRNewswire/ — HESCO products have been protecting the brave servicemen and women of the United States military for over 20 years, and now, Hesco brings that protection to the heroes of law enforcement after Hesco Bastion, Inc. completed the purchase of a controlling interest in Reed Composite Solutions (RCS), a specialist manufacturer of ballistic resistant body armor. RCS is to be called Hesco Armor , LLC, and will continue the Hesco tradition of being synonymous with protection and security […]
Retail giant Wal-Mart Stores, Inc. ( WMT ) recently announced that it has appointed Kevin Systrom to its board of directors effective from Sep 26. Systrom is a software engineer and co-founder and chief executive officer (CEO) of photo-sharing service Instagram, which was acquired by social networking company Facebook, Inc […]
Tetra Tech Inc. ( TTEK ) announced that it has recently received an Indefinite Delivery-Indefinite Quantity (IDIQ) contract worth nearly $30 million from the National Institute of Standards and Technology (NIST). Along with this, the company received three more IDIQ contracts from the U.S. […]
Pipeline updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight into the commercial potential of the candidate once it is successfully developed and commercialized. Valeant Pharmaceuticals International, Inc. […]
Zacks Investment Research upgraded Crown Castle International ( CCI ) by a notch to a Zacks Rank #2 (Buy) on Sep 30, 2014. Why the Upgrade? Higher usage of smartphones and tablets and increased deployment of 4G LTE networks have propelled demand for tower requirement by large carriers. […]
Sporting goods retailer Hibbett Sports Inc. ( HIBB ), managed to post better-than-expected bottom-line results for second-quarter fiscal 2015 despite reduced margins due to higher markdowns and increased input as well as operating costs. The company’s earnings of 32 cents per share surpassed the Zacks Consensus Estimate by a penny and matched the higher end of the company’s recent cautious forecast of 30–32 cents per share. […]
Shares of Avon Products Inc. ( AVP ) have lost much of its momentum and yesterday this New York-based global beauty retailer stock hit a new 52-week low of $12.45. We believe that the recently announced resignation of the company’s Chief Financial Officer (CFO) and Executive Vice President, Kimberly Ross, has made investors cautious about the company’s prospects. […]
[marketwatch EE5C55A5-A54F-4CE2-A16B-82FE6D86D0A2] Want to Stay Married? Get a Degree […]
[marketwatch F85B2A0B-3217-4366-9223-4BA5C45BD108] Two-Thirds of Cancer Survivors Incur Debt […]
[marketwatch 64166BDF-94BA-4F8B-9B29-C7EEF6B157A0] Patients Play Researchers in Drug Trials […]
Zacks Investment Research downgraded shares of Range Resources Corporation (RRC) from NEUTRAL to UNDERPERFORM on September 30, 2014, with a target price of $62.00. We are downgrading our rating on Range Resources to Underperform from Neutral. The company remains exposed to volatile natural gas fundamentals, interest rate risks and the uncertain macro backdrop. […]
Zacks Investment Research downgraded shares of Tonix Pharmaceuticals (TNXP) from OUTPERFORM to NEUTRAL on September 30, 2014, with a target price of $8.00. Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day . […]
Zacks Investment Research upgraded shares of Bio Light Israeli (BLGTY) from N/A to OUTPERFORM on September 30, 2014, with a target price of $14.00. BioLight Israeli Life Sciences invests in, manages and commercializes biomedical innovations in the field of ophthalmology and cancer diagnostics. […]
As part of its effort to enhance financial flexibility, Hudson Pacific Properties, Inc. ( HPP ) closed the amending and restating of its $250 million unsecured revolving credit facility effective Sep 23, 2014. […]
On Sep 24, 2014, we issued an updated research report on BankUnited, Inc. ( BKU ). […]
Zacks Investment Research downgraded Applied Industrial Technologies ( AIT ) to a Zacks Rank #5 (Strong Sell) on Sep 30, 2014. Going by the Zacks model, companies holding a Zacks Rank #5 have strong chances of performing worse than the broader market. […]
On Sep 30, Zacks Investment Research downgraded SEI Investments Co. ( SEIC ) to a Zacks Rank #3 (Hold). Going by the Zacks model, companies holding a Zacks Rank #3 are expected to perform in line with the broader market. […]
Copyright © 2024 | MH Magazine WordPress Theme by MH Themes